Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer’s disease ; volume:6 ; number:4 ; day:14 ; month:7 ; year:2014 ; pages:1-12 ; date:8.2014
Alzheimer's research & therapy ; 6, Heft 4 (14.7.2014), 1-12, 8.2014
- Creator
-
Alzate, Oscar
- Contributor
-
Osorio, Cristina
DeKroon, Robert M.
Corcimaru, Ana
Gunawardena, Harsha P.
SpringerLink (Online service)
- DOI
-
10.1186/alzrt273
- URN
-
urn:nbn:de:1111-2016073131945
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alzate, Oscar
- Osorio, Cristina
- DeKroon, Robert M.
- Corcimaru, Ana
- Gunawardena, Harsha P.
- SpringerLink (Online service)
Other Objects (12)
The effect of apolipoprotein E isoforms and sortilin in brain lipid homeostasis and Alzheimer’s disease
Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
Apolipoprotein E and Alzheimer's disease : with 10 tables
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions
The effect of apolipoprotein E isoforms and sortilin in brain lipid homeostasis and Alzheimer’s disease
Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
Apolipoprotein E and Alzheimer's disease : with 10 tables
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions
The effect of apolipoprotein E isoforms and sortilin in brain lipid homeostasis and Alzheimer’s disease
Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
Apolipoprotein E and Alzheimer's disease : with 10 tables
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease